127 related articles for article (PubMed ID: 33073482)
1. The chromogranin A
Rocca C; Grande F; Granieri MC; Colombo B; De Bartolo A; Giordano F; Rago V; Amodio N; Tota B; Cerra MC; Rizzuti B; Corti A; Angelone T; Pasqua T
Acta Physiol (Oxf); 2021 Apr; 231(4):e13570. PubMed ID: 33073482
[TBL] [Abstract][Full Text] [Related]
2. Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart.
Cerra MC; De Iuri L; Angelone T; Corti A; Tota B
Basic Res Cardiol; 2006 Jan; 101(1):43-52. PubMed ID: 16151967
[TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 Engagement.
Dallatomasina A; Gasparri AM; Colombo B; Sacchi A; Bianco M; Daniele T; Esposito A; Pastorino F; Ponzoni M; Marcucci F; Curnis F; Corti A
Cancer Res; 2019 Apr; 79(8):1925-1937. PubMed ID: 30796053
[TBL] [Abstract][Full Text] [Related]
4. The homologous rat chromogranin A1-64 (rCGA1-64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide.
Cerra MC; Gallo MP; Angelone T; Quintieri AM; Pulerà E; Filice E; Guérold B; Shooshtarizadeh P; Levi R; Ramella R; Brero A; Boero O; Metz-Boutigue MH; Tota B; Alloatti G
FASEB J; 2008 Nov; 22(11):3992-4004. PubMed ID: 18697842
[TBL] [Abstract][Full Text] [Related]
5. Quantification of Chromogranin A and Its Fragments in Biological Fluids.
Curnis F; Colombo B; Corti A
Methods Mol Biol; 2023; 2565():343-359. PubMed ID: 36205905
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of vasostatin-1, a chromogranin A fragment, are associated with carotid artery maximum stenosis: A pilot study.
Bachetti T; Ferrari Bardile A; Aloi TL; Colombo B; Assi E; Savino G; Vercelli A; Colombo R; Corti A
Int J Cardiol; 2017 Jun; 236():438-443. PubMed ID: 28190616
[TBL] [Abstract][Full Text] [Related]
7. Full-length human chromogranin-A cardioactivity: myocardial, coronary, and stimulus-induced processing evidence in normotensive and hypertensive male rat hearts.
Pasqua T; Corti A; Gentile S; Pochini L; Bianco M; Metz-Boutigue MH; Cerra MC; Tota B; Angelone T
Endocrinology; 2013 Sep; 154(9):3353-65. PubMed ID: 23751870
[TBL] [Abstract][Full Text] [Related]
8. Endothelium-derived nitric oxide mediates the antiadrenergic effect of human vasostatin-1 in rat ventricular myocardium.
Gallo MP; Levi R; Ramella R; Brero A; Boero O; Tota B; Alloatti G
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2906-12. PubMed ID: 17293489
[TBL] [Abstract][Full Text] [Related]
9. A new chromogranin A-dependent angiogenic switch activated by thrombin.
Crippa L; Bianco M; Colombo B; Gasparri AM; Ferrero E; Loh YP; Curnis F; Corti A
Blood; 2013 Jan; 121(2):392-402. PubMed ID: 23190532
[TBL] [Abstract][Full Text] [Related]
10. The interplay between chromogranin A-derived peptides and cardiac natriuretic peptides in cardioprotection against catecholamine-evoked stress.
Mazza R; Imbrogno S; Tota B
Regul Pept; 2010 Nov; 165(1):86-94. PubMed ID: 20594992
[TBL] [Abstract][Full Text] [Related]
11. Human recombinant vasostatin-1 may interfere with cell-extracellular matrix interactions.
Di Felice V; Cappello F; Montalbano A; Ardizzone N; Campanella C; De Luca A; Amelio D; Tota B; Corti A; Zummo G
Ann N Y Acad Sci; 2006 Dec; 1090():305-10. PubMed ID: 17384274
[TBL] [Abstract][Full Text] [Related]
12. Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phosphatidylethanolamine.
Blois A; Holmsen H; Martino G; Corti A; Metz-Boutigue MH; Helle KB
Regul Pept; 2006 Mar; 134(1):30-7. PubMed ID: 16445995
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the antihypertensive catestatin.
Angelone T; Quintieri AM; Pasqua T; Gentile S; Tota B; Mahata SK; Cerra MC
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(2):H431-42. PubMed ID: 22058158
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models.
Bianco M; Gasparri A; Generoso L; Assi E; Colombo B; Scarfò L; Bertilaccio MT; Scielzo C; Ranghetti P; Dondossola E; Ponzoni M; Caligaris-Cappio F; Ghia P; Corti A
Oncotarget; 2016 Jul; 7(27):41725-41736. PubMed ID: 27203389
[TBL] [Abstract][Full Text] [Related]
15. Cytoskeleton mediates negative inotropism and lusitropism of chromogranin A-derived peptides (human vasostatin1-78 and rat CgA₁₋₆₄) in the rat heart.
Angelone T; Quintieri AM; Goumon Y; Di Felice V; Filice E; Gattuso A; Mazza R; Corti A; Tota B; Metz-Boutigue MH; Cerra MC
Regul Pept; 2010 Nov; 165(1):78-85. PubMed ID: 19896507
[TBL] [Abstract][Full Text] [Related]
16. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
[TBL] [Abstract][Full Text] [Related]
17. Chromogranin A: secretion of processed products from the stimulated retrogradely perfused bovine adrenal gland.
Helle KB; Marley PD; Angeletti RH; Aunis D; Galindo E; Small DH; Livett BG
J Neuroendocrinol; 1993 Aug; 5(4):413-20. PubMed ID: 7691355
[TBL] [Abstract][Full Text] [Related]
18. Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism.
Cappello S; Angelone T; Tota B; Pagliaro P; Penna C; Rastaldo R; Corti A; Losano G; Cerra MC
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H719-27. PubMed ID: 17416598
[TBL] [Abstract][Full Text] [Related]
19. Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function.
Pieroni M; Corti A; Tota B; Curnis F; Angelone T; Colombo B; Cerra MC; Bellocci F; Crea F; Maseri A
Eur Heart J; 2007 May; 28(9):1117-27. PubMed ID: 17389654
[TBL] [Abstract][Full Text] [Related]
20. Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms.
Corsello A; Di Filippo L; Massironi S; Sileo F; Dolcetta Capuzzo A; Gemma M; Carlucci C; Cusini C; Colombo B; Dallatomasina A; Franchi GM; Corti A; Manzoni MF
PLoS One; 2018; 13(5):e0196858. PubMed ID: 29723285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
